Skip to content
Search

Latest Stories

UK official caught Covid-19 during India visit aimed at securing vaccine

UK official caught Covid-19 during India visit aimed at securing vaccine

A British government official, who visited India last month to secure vaccine supplies for the UK, has tested positive for COVID-19 on his return and is among those believed to have unwittingly carried the so-called Indian variant of the contagion to Britain, according to a media report on Sunday.

David Quarrey, 55, a 10 Downing Street aide, had tested negative in his pre-travel test but tested positive a week after his return when the NHS flagged that someone on his flight had been traced as COVID-positive, The Sunday Times reports.


Boris Johnson’s International Affairs Adviser and Deputy National Security Adviser Quarrey’s tour in March was among the precursor visits ahead of the UK prime minister’s scheduled visit in April. Johnson’s visit was, however, cancelled last week amidst the escalating pandemic crisis in India.

“Mr Quarrey followed the correct procedures on his return to the UK,” a government spokesperson said.

The former diplomat went to India with Johnson’s ally Lord Edward Udny-Lister as part of an effort to secure millions of doses of the Oxford/AstraZeneca vaccine, being produced by the Serum Institute of India -- the world’s largest vaccine maker -- as part of an international tie-up.

According to the newspaper, Quarrey, who is exempt from quarantine and testing requirements as he was on an official government business, tested negative for COVID-19 when he took a pre-departure test on March 25.

However, a week later on April 1 when he was back at work at Downing Street, he received a message from the NHS Test and Trace team because someone on the same flight had tested positive. He took a test the same day and was also found to be positive.

India has since been added to the “red list” of 40 countries from where travel is either banned or severely restricted, with compulsory 10-day hotel quarantines in place for any returning local residents.

The Public Health England (PHE) has tracked 132 cases of the B.1.617 India variant until the middle of April and continues to monitor it as a Variant Under Investigation (VUI).

Meanwhile, the Indian High Commission in London on Saturday issued a social media appeal for help to meet the rising demand for oxygen and medical supplies in India’s devastating second wave of the COVIS-19 pandemic.

It listed the required items as “empty, refillable oxygen cylinders with 10 litres and 45 litres LMO (liquid medical oxygen) capacity; oxygen concentrators; and Remdesivir” among the required supplies to meet the massive demand for these amid some of the highest coronavirus infection rates being recorded in India.

Several fundraising appeals have also been issued by UK-based charities via social media channels, including an emergency Covid appeal by the Prince Charles founded British Asian Trust and the Neasden Temple in London.

India is struggling with a second wave of the pandemic with more than 3,00,000 daily new coronavirus cases being reported in the past few days, and hospitals in several states are reeling under a shortage of medical oxygen and beds.

Since Friday, the IAF has been airlifting empty oxygen tankers and containers to various filling stations across the country to speed up the distribution of the much-needed medical oxygen in treating COVID-19 patients.

On Friday, the Union Home Ministry said it was in talks for the import of high-capacity oxygen-carrying tankers from Singapore and the UAE.

More For You

The Chase’s Paul Sinha shares Parkinson’s update after major health scare

Sinha’s message was one of resilience and realism

Getty

The Chase’s Paul Sinha shares Parkinson’s update after major health scare

Paul Sinha, known to viewers of ITV’s The Chase as “The Sinnerman,” has spoken candidly about his experience living with Parkinson’s disease. During an appearance on Loose Women on Thursday, 17 April, the comedian and quizzer reflected on his journey from diagnosis to managing the condition day to day.

Sinha, who was diagnosed with the progressive neurological disorder in 2019, revealed that his earliest symptoms were not what many would typically associate with Parkinson’s.

Keep ReadingShow less
Toblerone dark chocolate discontinued in the UK, confirms Mondelez

This reflects both the popularity of the product and the frustration of fans

iStock

Toblerone dark chocolate discontinued in the UK, confirms Mondelez

Toblerone fans in the UK will no longer be able to purchase the dark chocolate version of the iconic Swiss chocolate bar, as manufacturer Mondelez has confirmed it has discontinued the product.

The company stated that it has made the “difficult decision” to stop production of the 360g Toblerone Dark bar. While no specific reason was given, Mondelez acknowledged the disappointment it may cause among consumers. A spokesperson said: “While we understand that this may be disappointing for some consumers, we continue to invest in Toblerone.”

Keep ReadingShow less
Crispello Comeback: Cadbury’s Light Treat Hits B&M Shelves

The return to UK shelves has brought a wave of nostalgia for many

Getty

Cadbury Crispello chocolate bars return to UK shelves at B&M for 49p

Cadbury's Crispello chocolate bars have made a surprise return to UK stores, now available at B&M for just 49p. The product, a mix of light wafer and smooth chocolate, had previously been discontinued in the UK and was only available overseas in recent years.

Each individual pack of Crispello contains four chocolate-covered wafer fingers, filled with a creamy chocolate centre. The sweet treat has gained attention on social media, with shoppers expressing their excitement about its reappearance in British stores.

Keep ReadingShow less
 Sharon Osbourne

Celebrities including Sharon Osbourne and Oprah Winfrey might be exhibiting signs of this side effect

Instagram/ Sharonosbourne

‘Ozempic feet’ joins growing list of unusual side effects linked to popular weight-loss drug

Ozempic, the blockbuster weight-loss medication that has surged in popularity across the United States and among celebrities, is now being linked to a new and unexpected side effect like sagging skin on the feet, informally dubbed “Ozempic feet”.

Medical experts say the condition is caused by rapid fat loss, which not only alters the appearance of the face and buttocks, but can also lead to aesthetic changes in the feet. As the drug continues to make headlines for its weight-loss benefits, concerns about such side effects are also gaining attention.

Keep ReadingShow less